Subscribe to RSS
DOI: 10.1055/s-0038-1670660
Venous Thrombosis Risk after Arthroscopy of the Knee: Derivation and Validation of the L-TRiP(ascopy) Score
Funding Netherlands Heart Foundation (grant NHS 98.113), Netherlands Organization for Scientific Research (grant 912–03–033|2003) and Dutch Cancer Foundation (grant RUL 99/1992) funded the study. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.Publication History
04 March 2018
08 August 2018
Publication Date:
20 September 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/201810/lookinside/thumbnails/10-1055-s-0038-1670660_180169-1.jpg)
Abstract
Patients at high risk for venous thrombosis (VT) following knee arthroscopy could potentially benefit from thromboprophylaxis. We explored the predictive values of environmental, genetic risk factors and levels of coagulation markers to integrate these into a prediction model. Using a population-based case–control study into the aetiology of VT, we developed a Complete (all variables), Screening (easy to use in clinical practice) and Clinical (only environmental risk factors) model. The Clinical model was transformed into the Leiden-Thrombosis Risk Prediction (arthroscopy) score [L-TRiP(ascopy) score]. Model validation was performed both internally and externally in another case–control study. A total of 4,943 cases and 6,294 controls were maintained in the analyses, 107 cases and 26 controls had undergone knee arthroscopy. Twelve predictor variables (8 environmental, 3 haemorheological and 1 genetic) were selected from 52 candidates and incorporated into the Complete model (area under the curve [AUC] of 0.81, 95% confidence interval [CI], 0.76–0.86). The Screening model (9 predictors: environmental factors plus factor VIII activity) reached an AUC of 0.76 (95% CI, 0.64–0.88) and the Clinical (and corresponding L-TRiP(ascopy)) model an AUC of 0.72 (95% CI, 0.60–0.83). In the internal and external validation, the Complete model reached an AUC of 0.78 (95% CI, 0.52–0.98) and 0.75 (95% CI, 0.42–1.00), respectively, while the other models performed slightly less well.
Authors' Contributions
B. Nemeth, R.A. van Adrichem, R.G.H.N. Nelissen, S.C. Cannegieter and F.R. Rosendaal designed the research. T. Baglin, F.R. Rosendaal and A. van Hylckama Vlieg enrolled patients. B. Nemeth and S. le Cessie performed the analyses. B. Nemeth wrote the first draft of the manuscript. All authors critically revised the manuscript content. B. Nemeth takes full responsibility for data analyses and all authors take responsibility for the interpretation of the data. All authors have read, and confirm that they meet, ICMJE criteria for authorship.
-
References
- 1 Geerts WH, Bergqvist D, Pineo GF. , et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines, 8th ed. Chest 2008; 133 (6 Suppl): 381S-453S
- 2 Krych AJ, Sousa PL, Morgan JA, Levy BA, Stuart MJ, Dahm DL. Incidence and risk factor analysis of symptomatic venous thromboembolism after knee arthroscopy. Arthroscopy 2015; 31 (11) 2112-2118
- 3 Mauck KF, Froehling DA, Daniels PR. , et al. Incidence of venous thromboembolism after elective knee arthroscopic surgery: a historical cohort study. J Thromb Haemost 2013; 11 (07) 1279-1286
- 4 Ettema HB, Hoppener MR, Veeger NJ, Büller HR, van der Meer J. Low incidence of venographically detected deep vein thrombosis after knee arthroscopy without thromboprophylaxis: a prospective cohort study. J Thromb Haemost 2006; 4 (06) 1411-1413
- 5 Camporese G, Bernardi E, Prandoni P. , et al; KANT (Knee Arthroscopy Nadroparin Thromboprophylaxis) Study Group. Low-molecular-weight heparin versus compression stockings for thromboprophylaxis after knee arthroscopy: a randomized trial. Ann Intern Med 2008; 149 (02) 73-82
- 6 Gaskill T, Pullen M, Bryant B, Sicignano N, Evans AM, DeMaio M. The prevalence of symptomatic deep venous thrombosis and pulmonary embolism after anterior cruciate ligament reconstruction. Am J Sports Med 2015; 43 (11) 2714-2719
- 7 American Academy of Orthopaedic Surgeons. Knee arthroscopy; 2015. Available at: http://orthoinfo.aaos.org/topic.cfm?topic=a00299 . Accessed October 22, 2015
- 8 Eynon AM, James S, Leach P. Thromboembolic events after arthroscopic knee surgery. Arthroscopy 2004; 20 (Suppl. 02) 23-24
- 9 Navarro-Sanz A, Fernández-Ortega JF. Fatal pulmonary embolism after knee arthroscopy. Am J Sports Med 2004; 32 (02) 525-528
- 10 Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost 2007; 5 (04) 692-699
- 11 Kahn SR, Shrier I, Julian JA. , et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008; 149 (10) 698-707
- 12 van Adrichem RA, Nemeth B, Algra A. , et al; POT-KAST and POT-CAST Group. Thromboprophylaxis after knee arthroscopy and lower-leg casting. N Engl J Med 2017; 376 (06) 515-525
- 13 Greene JW, Deshmukh AJ, Cushner FD. Thromboembolic complications in arthroscopic surgery. Sports Med Arthrosc Rev 2013; 21 (02) 69-74
- 14 van Adrichem RA, Debeij J, Nelissen RG, Schipper IB, Rosendaal FR, Cannegieter SC. Below-knee cast immobilization and the risk of venous thrombosis: results from a large population-based case-control study. J Thromb Haemost 2014; 12 (09) 1461-1469
- 15 Falck-Ytter Y, Francis CW, Johanson NA. , et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed.: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2 Suppl): e278S-e325S
- 16 Blom JW, Doggen CJ, Osanto S, Rosendaal FR. Malignancies, prothrombotic mutations, and the risk of venous thrombosis. JAMA 2005; 293 (06) 715-722
- 17 Nemeth B, van Adrichem RA, van Hylckama Vlieg A. , et al. Venous thrombosis risk after cast immobilization of the lower extremity: derivation and validation of a clinical prediction score, L-TRiP(cast), in three population-based case-control studies. PLoS Med 2015; 12 (11) e1001899
- 18 van Hylckama Vlieg A, Baglin CA, Luddington R, MacDonald S, Rosendaal FR, Baglin TP. The risk of a first and a recurrent venous thrombosis associated with an elevated D-dimer level and an elevated thrombin potential: results of the THE-VTE study. J Thromb Haemost 2015; 13 (09) 1642-1652
- 19 van Adrichem RA, Nelissen RG, Schipper IB, Rosendaal FR, Cannegieter SC. Risk of venous thrombosis after arthroscopy of the knee: results from a large population-based case-control study. J Thromb Haemost 2015; 13 (08) 1441-1448
- 20 Bohensky MA, deSteiger R, Kondogiannis C. , et al. Adverse outcomes associated with elective knee arthroscopy: a population-based cohort study. Arthroscopy 2013; 29 (04) 716-725
- 21 Hetsroni I, Lyman S, Do H, Mann G, Marx RG. Symptomatic pulmonary embolism after outpatient arthroscopic procedures of the knee: the incidence and risk factors in 418,323 arthroscopies. J Bone Joint Surg Br 2011; 93 (01) 47-51
- 22 Jameson SS, Dowen D, James P, Serrano-Pedraza I, Reed MR, Deehan DJ. The burden of arthroscopy of the knee: a contemporary analysis of data from the English NHS. J Bone Joint Surg Br 2011; 93 (10) 1327-1333
- 23 Caprini JA. Thrombosis risk assessment as a guide to quality patient care. Dis Mon 2005; 51 (2-3): 70-78
- 24 Schonenberg D, van Meeteren M, Nelissen RG, van der Horst-Bruinsma IE, Pöll RG, Nurmohamed MT. Thrombosis prevention in orthopaedic surgery: clinical practice in the Netherlands in 2002 [in Dutch]. Ned Tijdschr Geneeskd 2003; 147 (38) 1856-1860